|
Stryker Corporation (SYK) DCF Valuation
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Stryker Corporation (SYK) Bundle
Looking to assess the intrinsic value of Stryker Corporation? Our SYK DCF Calculator integrates real-world data with extensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,351.0 | 17,108.0 | 18,449.0 | 20,498.0 | 22,595.0 | 25,328.2 | 28,392.1 | 31,826.5 | 35,676.4 | 39,992.0 |
| Revenue Growth, % | 0 | 19.21 | 7.84 | 11.11 | 10.23 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 |
| EBITDA | 3,755.0 | 4,646.0 | 4,536.0 | 4,934.0 | 5,716.0 | 6,447.4 | 7,227.3 | 8,101.6 | 9,081.6 | 10,180.2 |
| EBITDA, % | 26.17 | 27.16 | 24.59 | 24.07 | 25.3 | 25.46 | 25.46 | 25.46 | 25.46 | 25.46 |
| Depreciation | 812.0 | 990.0 | 998.0 | 1,028.0 | 1,050.0 | 1,343.2 | 1,505.7 | 1,687.9 | 1,892.0 | 2,120.9 |
| Depreciation, % | 5.66 | 5.79 | 5.41 | 5.02 | 4.65 | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 |
| EBIT | 2,943.0 | 3,656.0 | 3,538.0 | 3,906.0 | 4,666.0 | 5,104.2 | 5,721.6 | 6,413.7 | 7,189.6 | 8,059.3 |
| EBIT, % | 20.51 | 21.37 | 19.18 | 19.06 | 20.65 | 20.15 | 20.15 | 20.15 | 20.15 | 20.15 |
| Total Cash | 3,024.0 | 3,019.0 | 1,928.0 | 3,053.0 | 4,402.0 | 4,232.1 | 4,744.0 | 5,317.9 | 5,961.2 | 6,682.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,701.0 | 3,022.0 | 3,565.0 | 3,765.0 | 3,987.0 | 4,651.4 | 5,214.0 | 5,844.7 | 6,551.8 | 7,344.3 |
| Account Receivables, % | 18.82 | 17.66 | 19.32 | 18.37 | 17.65 | 18.36 | 18.36 | 18.36 | 18.36 | 18.36 |
| Inventories | 3,494.0 | 3,314.0 | 3,995.0 | 4,843.0 | 4,774.0 | 5,578.7 | 6,253.5 | 7,009.9 | 7,857.9 | 8,808.4 |
| Inventories, % | 24.35 | 19.37 | 21.65 | 23.63 | 21.13 | 22.03 | 22.03 | 22.03 | 22.03 | 22.03 |
| Accounts Payable | 810.0 | 1,129.0 | 1,413.0 | 1,517.0 | 1,679.0 | 1,759.5 | 1,972.3 | 2,210.9 | 2,478.4 | 2,778.2 |
| Accounts Payable, % | 5.64 | 6.6 | 7.66 | 7.4 | 7.43 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 |
| Capital Expenditure | -487.0 | -525.0 | -588.0 | -575.0 | -755.0 | -800.2 | -897.0 | -1,005.5 | -1,127.1 | -1,263.4 |
| Capital Expenditure, % | -3.39 | -3.07 | -3.19 | -2.81 | -3.34 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 |
| Tax Rate, % | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 | 14.29 |
| EBITAT | 2,408.3 | 3,196.0 | 3,109.4 | 3,365.8 | 3,999.2 | 4,379.5 | 4,909.3 | 5,503.2 | 6,168.9 | 6,915.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,651.7 | 3,839.0 | 2,579.4 | 2,874.8 | 4,303.2 | 3,534.1 | 4,493.4 | 5,037.0 | 5,646.3 | 6,329.3 |
| WACC, % | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 19,283.5 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 6,582 | |||||||||
| Terminal Value | 145,242 | |||||||||
| Present Terminal Value | 96,450 | |||||||||
| Enterprise Value | 115,733 | |||||||||
| Net Debt | -2,243 | |||||||||
| Equity Value | 117,976 | |||||||||
| Diluted Shares Outstanding, MM | 386 | |||||||||
| Equity Value Per Share | 305.96 |
What You Will Get
- Editable Forecast Inputs: Easily adjust assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: Stryker Corporation’s (SYK) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that tailors to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Customizable Financial Inputs: Adjust essential factors such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and various outputs in real-time.
- High-Precision Accuracy: Leverages Stryker Corporation’s (SYK) actual financial data for dependable valuation results.
- Simplified Scenario Analysis: Effortlessly evaluate different assumptions and analyze results side-by-side.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Stryker Corporation (SYK) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Stryker Corporation (SYK)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Stryker Corporation (SYK)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses all in one convenient package.
- Customizable Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Stryker’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Stryker Corporation (SYK).
Who Should Use This Product?
- Healthcare Professionals: Understand the financial metrics that drive companies like Stryker Corporation (SYK).
- Researchers: Utilize advanced models to analyze trends in the medical device industry.
- Investors: Evaluate your investment strategies and assess the valuation of Stryker Corporation (SYK).
- Financial Analysts: Enhance your analysis with a customizable DCF model specifically for Stryker Corporation (SYK).
- Business Students: Explore how major players like Stryker Corporation (SYK) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Stryker Corporation (SYK) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Stryker Corporation (SYK).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.